Literature DB >> 20801631

An increase in liver PPARγ2 is an initial event to induce fatty liver in response to a diet high in butter: PPARγ2 knockdown improves fatty liver induced by high-saturated fat.

Tomomi Yamazaki1, Sayaka Shiraishi, Kyoko Kishimoto, Shinji Miura, Osamu Ezaki.   

Abstract

The effects of a diet rich in saturated fat on fatty liver formation and the related mechanisms that induce fatty liver were examined. C57BL/6J mice were fed butter or safflower oil as a high-fat (HF) diet (40% fat calories) for 2, 4, 10, or 17 weeks. Although both HF diets induced similar levels of obesity, HF butter-fed mice showed a two to threefold increase in liver triacylglycerol (TG) concentration compared to HF safflower oil-fed mice at 4 or 10 weeks without hyperinsulinemia. At 4 weeks, increases in peroxisome proliferator-activated receptor γ2 (PPARγ2), CD36, and adipose differentiation-related protein (ADRP) mRNAs were observed in HF butter-fed mice; at 10 weeks, an increase in sterol regulatory element-binding protein-1c (SREBP-1c) was observed; at 17 weeks, these increases were attenuated. At 4 weeks, a single injection of adenoviral vector-based short hairpin interfering RNA against PPARγ2 in HF butter-fed mice reduced PPARγ protein and mRNA of its target genes (CD36 and ADRP) by 43%, 43%, and 39%, respectively, with a reduction in liver TG concentration by 38% in 5 days. PPARγ2 knockdown also reduced mRNAs in lipogenic genes (fatty-acid-synthase, stearoyl-CoA desaturase 1, acetyl-CoA carboxylase 1) without alteration of SREBP-1c mRNA. PPARγ2 knockdown reduced mRNAs in genes related to inflammation (CD68, interleukin-1β, tumor necrosis factor-α, and monocyte chemoattractant protein-1). In conclusion, saturated fatty acid-rich oil induced fatty liver in mice, and this was triggered initially by an increase in PPARγ2 protein in the liver, which led to increased expression of lipogenic genes. Inactivation of PPARγ2 may improve fatty liver induced by HF saturated fat.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20801631     DOI: 10.1016/j.jnutbio.2010.04.009

Source DB:  PubMed          Journal:  J Nutr Biochem        ISSN: 0955-2863            Impact factor:   6.048


  33 in total

1.  The ddY mouse: a model of postprandial hypertriglyceridemia in response to dietary fat.

Authors:  Tomomi Yamazaki; Kyoko Kishimoto; Osamu Ezaki
Journal:  J Lipid Res       Date:  2012-06-26       Impact factor: 5.922

2.  Inhibition of hepatocyte nuclear factor 1b induces hepatic steatosis through DPP4/NOX1-mediated regulation of superoxide.

Authors:  Zi Long; Meng Cao; Shuhao Su; Guangyuan Wu; Fansen Meng; Hao Wu; Jiangzheng Liu; Weihua Yu; Kamran Atabai; Xin Wang
Journal:  Free Radic Biol Med       Date:  2017-09-21       Impact factor: 7.376

3.  Pharmacological ER stress promotes hepatic lipogenesis and lipid droplet formation.

Authors:  Jin-Sook Lee; Roberto Mendez; Henry H Heng; Zeng-Quan Yang; Kezhong Zhang
Journal:  Am J Transl Res       Date:  2012-01-06       Impact factor: 4.060

4.  Hepatocyte-specific, PPARγ-regulated mechanisms to promote steatosis in adult mice.

Authors:  Abigail Wolf Greenstein; Neena Majumdar; Peng Yang; Papasani V Subbaiah; Rhonda D Kineman; Jose Cordoba-Chacon
Journal:  J Endocrinol       Date:  2016-10-31       Impact factor: 4.286

5.  Herpesvirus-associated ubiquitin-specific protease (HAUSP) modulates peroxisome proliferator-activated receptor γ (PPARγ) stability through its deubiquitinating activity.

Authors:  Kyeong Won Lee; Jin Gu Cho; Chul Min Kim; A Young Kang; Min Kim; Byung Yong Ahn; Sung Soo Chung; Key-Hwan Lim; Kwang-Hyun Baek; Jong-Hyuk Sung; Kyong Soo Park; Sang Gyu Park
Journal:  J Biol Chem       Date:  2013-09-26       Impact factor: 5.157

6.  Enhanced ethanol catabolism in orphan nuclear receptor SHP-null mice.

Authors:  Jung Eun Park; Mikang Lee; Ryan Mifflin; Yoon Kwang Lee
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-03-11       Impact factor: 4.052

7.  Human GDPD3 overexpression promotes liver steatosis by increasing lysophosphatidic acid production and fatty acid uptake.

Authors:  Chia-Chi C Key; Andrew C Bishop; Xianfeng Wang; Qingxia Zhao; Guan-Yuan Chen; Matthew A Quinn; Xuewei Zhu; Qibin Zhang; John S Parks
Journal:  J Lipid Res       Date:  2020-05-19       Impact factor: 5.922

8.  Hepatic PPARγ Is Not Essential for the Rapid Development of Steatosis After Loss of Hepatic GH Signaling, in Adult Male Mice.

Authors:  Rhonda D Kineman; Neena Majumdar; Papasani V Subbaiah; Jose Cordoba-Chacon
Journal:  Endocrinology       Date:  2016-03-07       Impact factor: 4.736

9.  Glucose-induced metabolic memory in Schwann cells: prevention by PPAR agonists.

Authors:  Esther S Kim; Fumiko Isoda; Irwin Kurland; Charles V Mobbs
Journal:  Endocrinology       Date:  2013-05-24       Impact factor: 4.736

10.  All-trans-retinoic acid ameliorates hepatic steatosis in mice by a novel transcriptional cascade.

Authors:  Seong Chul Kim; Chun-Ki Kim; David Axe; Aaron Cook; Mikang Lee; Tiangang Li; Nicole Smallwood; John Y L Chiang; James P Hardwick; David D Moore; Yoon Kwang Lee
Journal:  Hepatology       Date:  2014-03-26       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.